The implant — designated a breakthrough device by the FDA — would treat patients with pulmonary arterial hypertension. The progressive disease leads to heart failure but is usually treated with medication.
Aria CV Inc., a new startup, has licensed technology from the University of Minnesota to treat pulmonary hypertension. The company was formed in September and occupies discounted space within the University Enterprise Laboratories — called UEL Garage — in St. Paul, said John Scandurra, CEO of Aria CV. Scandurra and two other people invented the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.